Brain Thinning in OCD Traced to Synaptic Genes and Neurotransmitter Maps

Obsessive-compulsive disorder has long been described as a condition of circuits, a loop of intrusive thoughts and repetitive behaviors that seems to run on hardware buried deep in the brain. But what does that hardware actually look like, and what molecular machinery might be reshaping it? A new meta-analysis published in Translational Psychiatry offers one of the most detailed answers yet, combining brain imaging data from dozens of studies with gene expression atlases and neurotransmitter maps to argue that OCD is accompanied by measurable thinning of the cerebral cortex in specific, functionally meaningful regions, and that those structural changes align with genes governing synaptic signaling and the brain’s excitatory-inhibitory balance.

The research, led by Yufei Chen, Haoran Li, and Fenghua Long of West China Hospital of Sichuan University, together with Robert K. McNamara of the University of Cincinnati and senior author Fei Li, set out to resolve a stubborn inconsistency in the OCD literature. For years, structural MRI studies comparing cortical thickness, the width of the brain’s outer gray matter ribbon, between OCD patients and healthy controls have produced a patchwork of findings: some reported thinning in frontal regions, others in cingulate areas, and still others found no differences at all. Because cortical thickness is a sensitive marker of the health of neurons, synapses, and supporting glial cells within each cortical column, such inconsistency has made it difficult to build a coherent biological story about what the disorder does to the cortex.

To cut through the noise, the team performed a coordinate-based meta-analysis pooling cortical thickness comparisons across many independent studies of OCD patients and matched healthy controls. The approach treats each published brain map as a data point, allowing researchers to detect regions where structural differences reliably replicate across cohorts rather than appearing in only one or two samples. The results pointed to three regions where people with OCD consistently showed thinner cortex: the left posterior cingulate cortex, the left anterior cingulate cortex, and the right pars opercularis, a portion of the inferior frontal gyrus on the right side of the brain that plays a central role in response inhibition, the ability to stop an action already in progress.

The anatomical pattern is telling. The anterior and posterior cingulate cortices are core nodes of the default mode network, the set of regions most active when the mind wanders inward, ruminates, and generates self-referential thought, while the pars opercularis belongs to the cingulo-opercular network, which supports cognitive control and the suppression of inappropriate responses. Both networks have been repeatedly implicated in the characteristic symptoms of OCD, from persistent unwanted thoughts to compulsive behaviors that resist inhibition. The finding that cortical thinning concentrates precisely at the junction of these networks suggests that the structural substrate of the disorder may lie in the brain’s machinery for regulating internally directed thought and behavioral control.

Crucially, the researchers did not stop at the group-level map. They ran subgroup analyses and meta-regressions to ask whether clinical and methodological variables, factors that often differ between studies, were quietly shaping the results. Two stood out. In samples of medicated patients, and in samples with comorbid psychiatric conditions, additional cortical thinning emerged in the left inferior parietal lobule and the right posterior cingulate cortex. This is an important caveat for the field: medication status and comorbidity are not merely statistical nuisances but appear to leave their own signatures on cortical structure, meaning that studies enrolling different kinds of patient populations may legitimately reach different conclusions about where and how severely the cortex is affected in OCD.

The authors also flagged a note of scientific caution that adds credibility to the work. One of the three main findings, the thinning in the left anterior cingulate cortex, showed significant evidence of publication bias, the tendency of journals to publish positive results more readily than null ones. By transparently reporting this, the team signals that the left ACC finding should be interpreted with more caution than the others, while the posterior cingulate and pars opercularis results survived the standard robustness checks. In a literature notorious for small samples and inconsistent replication, this kind of self-scrutiny is exactly what meta-analytic science is supposed to provide.

The most ambitious part of the study, however, went beyond anatomy into molecular territory. Using spatial correlation methods, the researchers asked whether the brain regions showing cortical thinning in OCD are also the regions where particular genes are most highly expressed, drawing on transcriptomic atlases that map gene activity across the human cortex. The logic is straightforward: if a structural abnormality clusters in areas enriched for a specific set of genes, those genes become candidate molecular players in the disorder. The analysis revealed that the cortical thickness alterations in OCD were spatially associated with genes enriched in synaptic signaling and synaptic organization, the processes by which neurons form, maintain, and tune their connections with one another.

Zooming in further at the cellular level, the implicated genes were found to be highly expressed in excitatory neurons, inhibitory neurons, and glial cells, the three major cell classes that together build and support cortical circuits. This cellular profile points toward a disruption of excitatory-inhibitory balance, the delicate equilibrium between neurons that speed signals up and neurons that damp them down, as well as toward changes in signaling transmission efficiency, how effectively information moves through cortical microcircuits. Excitatory-inhibitory imbalance has emerged in recent years as a leading hypothesis for several psychiatric conditions, and this study provides structural and transcriptomic evidence that the same principle may apply to OCD, linking the macroscopic thinning seen on MRI to the microscopic choreography of synapses and cell types.

The molecular story extended to neurochemistry as well. When the team overlaid the cortical thinning map with atlases of neurotransmitter receptor and transporter density, they found associations with multiple neurotransmitter systems, principally glutamate, serotonin, dopamine, and gamma-aminobutyric acid, or GABA. The prominence of glutamate is particularly striking, because glutamate is the brain’s primary excitatory transmitter and has been repeatedly implicated in OCD by genetic, pharmacological, and imaging studies, including reports that glutamate-modulating agents can help some patients. The convergence of structural, transcriptomic, and receptor-level evidence on glutamatergic and synaptic pathways suggests that these systems may represent the most promising molecular targets for understanding, and eventually treating, the cortical abnormalities associated with the disorder.

The authors are careful to frame their molecular findings as hypothesis-generating rather than definitive. Spatial correlations between imaging maps and gene expression do not prove causation, and the cortical thickness differences observed in OCD could be causes, consequences, or compensatory responses related to the illness. Still, the study delivers something the field has lacked: a unified framework in which the inconsistent structural imaging literature is distilled into a small set of reliably affected regions, those regions are shown to be modulated by clinically meaningful factors like medication and comorbidity, and the whole pattern is anchored to a plausible molecular substrate centered on synaptic function and excitatory-inhibitory signaling. For a disorder that affects millions of people worldwide and often resists standard treatments, that framework offers a roadmap for the next generation of research, from cell-type-specific investigations of cingulate and frontal cortex to clinical trials aimed at the glutamate system. The work was supported by the Sichuan Science and Technology Program and conducted entirely on previously published, publicly available data, an approach that demonstrates how secondary analyses, done rigorously, can extract new biological insight from decades of accumulated brain imaging.

Subject of Research: Cortical thickness alterations and their molecular correlates in obsessive-compulsive disorder

Article Title: Reduced cortical thickness in obsessive-compulsive disorder and candidate molecular correlates

Article References: Chen, Y., Li, H., Long, F., Zhao, Y., McNamara, R. K., & Li, F. (2026). Reduced cortical thickness in obsessive-compulsive disorder and candidate molecular correlates. Translational Psychiatry. https://doi.org/10.1038/s41398-026-04510-8

Image Credits: AI Generated

DOI: 10.1038/s41398-026-04510-8

Keywords: obsessive-compulsive disorder, cortical thickness, meta-analysis, posterior cingulate cortex, anterior cingulate cortex, pars opercularis, synaptic signaling, excitatory-inhibitory balance, glutamate, serotonin, dopamine, GABA